Retractions aren’t enough: Why science has bigger problems

Andrew Gelman
Andrew Gelman

Scientific fraud isn’t what keeps Andrew Gelman, a professor of statistics at Columbia University in New York, up at night. Rather, it’s the sheer number of unreliable studies — uncorrected, unretracted — that have littered the literature. He tells us more, below.

Whatever the vast majority of retractions are, they’re a tiny fraction of the number of papers that are just wrong — by which I mean they present no good empirical evidence for their claims.

I’ve personally had to correct two of my published articles.   Continue reading Retractions aren’t enough: Why science has bigger problems

What happened after a journal decided to get tough on plagiarism?

Reiss
Carol Shoshkes Reiss

In July 2015, DNA and Cell Biology began routinely scanning manuscript submissions for plagiarism using iThenticate; since then, it’s rejected between four and six manuscripts each month for that reason alone. Additional submissions have been rejected after the journal realized the authors had digitally altered figures. The level of misconduct “shocked” editor-in-chief Carol Shoshkes Reiss, as she wrote in a recent editorial for the journal. She spoke to us about the strict measures the journal has adopted in response to these incidents.

Retraction Watch: Why did you decide to begin scanning submissions for plagiarized text using iThenticate™ software in July, 2015? Did something prompt that decision? Continue reading What happened after a journal decided to get tough on plagiarism?

In precedent break, BMJ explains why it rejected controversial “weekend effect” paper

After the reviewer of a rejected paper was publicly outed, the BMJ has taken the unusual step of explaining why it chose not to publish the paper.

The paper — eventually published in another journal — raised hackles for suggesting that there is no “weekend effect,” or a higher mortality rate in hospitals on Saturday and Sunday. This caught the attention of UK policy makers, who have proposed changing policies to compensate for any supposed “weekend effect.”

Amidst the heated discussion about the research, one of the reviewers was identified, along with suggestions that he may have been conflicted because he had published a study showing the opposite finding. Yesterday, the BMJ posted a blog explaining that it was the editors — and not one sole reviewer — who decided to reject the paper: Continue reading In precedent break, BMJ explains why it rejected controversial “weekend effect” paper

Publicly available data on thousands of OKCupid users pulled over copyright claim

okcupidThe Open Science Framework (OSF) has pulled a dataset from 70,000 users of the online dating site OkCupid over copyright concerns, according to the study author.

The release of the dataset generated concerns, by making personal information — including personality traits — publicly available.

Emil Kirkegaard, a master’s student at Aarhus University in Denmark, told us that the OSF removed the data from its site after OkCupid filed a claim under the Digital Millennium Copyright Act (DMCA), which requires the host of online content to remove it under certain conditions. Kirkegaard also submitted a paper based on this dataset to the journal he edits, Open Differential Psychology. But with the dataset no longer public, the fate of the paper is subject to “internal discussions,” he told us.

In place of the dataset on OSF, this message now appears: Continue reading Publicly available data on thousands of OKCupid users pulled over copyright claim

In major shift, medical journal to publish protocols along with clinical trials

AIMA major medical journal has updated its instructions to authors, now requiring that they publish protocols of clinical trials, along with any changes made along the way.

We learned of this change via the COMPare project, which has been tracking trial protocol changes in major medical journals — and been critical of the Annals of Internal Medicine‘s response to those changes. However, Darren Taichman, the executive deputy editor of the journal, told us the journal’s decision to publish trial protocols was a long time coming: Continue reading In major shift, medical journal to publish protocols along with clinical trials

Ever been asked to review your own paper? This economist was

Serdar Sayan
Serdar Sayan

“Eerily familiar”: That’s how Serdar Sayan of TOBB University of Economics and Technology in Turkey says it felt to read a submission to the Scandinavian Journal of Economics, after the journal asked him to review the manuscript. It turns out, it was Sayan’s paper, word for word, equation for equation, down to the last punctuation mark. But this wasn’t a case of authors faking email addresses for reviewers to rubber stamp their own work – instead, the author had plagiarized from a paper Sayan had published a few years earlier. Sayan describes the surreal experience in the Review of Social Economy (vol. 74, no. 1, 2016), in a paper titled: “Serving as a referee for your own paper: A dream come true or…?

“I have been asked by a journal to serve as a referee for my own paper. Obviously, this sounds just as unlikely, and probably almost as intriguing, as saying ‘I have attended my own funeral.’” — Serdar Sayan, Review of Social Economy (vol. 74, no. 1, 2016)

Retraction Watch: When you looked at the paper, how long did it take you to figure out what had happened? Continue reading Ever been asked to review your own paper? This economist was

Duke researcher adds another retraction in JCI, bringing count to 15

JCIWe’ve found another retraction for Erin Potts-Kant, a former researcher at Duke, bringing her total to 15.

Yesterday we reported on two new retractions for Potts-Kant in PLoS ONE, which earned her a spot in the top 30 on our leaderboard. As with the others, the latest paper, in the Journal of Clinical Investigation, is marred by “unreliable” data.

Here’s the retraction notice for “In utero supplementation with methyl donors enhances allergic airway disease in mice“:

Continue reading Duke researcher adds another retraction in JCI, bringing count to 15

Book publisher: Authors plagiarized “in good faith” because they cited previous work

A publisher has retracted a chapter from a book on flow cytometry after determining the authors plagiarized some material — but noted that because the authors cited the article they lifted from, they likely acted “in good faith.”

We were tipped off to this retraction from the authors of the review article the chapter plagiarized from, who told us they were upset by the incident and doubted whether the authors had performed the experiments they described in the chapter.

More broadly, the retraction raises an important question: How can publishers retract one chapter of a book, leaving the rest intact?

First, let’s take a look at the retraction notice: Continue reading Book publisher: Authors plagiarized “in good faith” because they cited previous work

Macchiarini did not obtain necessary ethics approvals, says Swedish Research Council

lancetSurgeon Paolo Macchiarini did not apply for the necessary ethics approval to perform the pioneering transplants he’s known for, according to the Swedish Research Council.

Chief Legal Counsel Anna Hörnlund, who wrote a letter in this week’s The Lancet, says Macchiarini’s work needed to obtain ethical approval from one of six regional ethical review boards, as required by Swedish law — and neither Macchiarini nor his former employer, Karolinska Institutet, did so:

Continue reading Macchiarini did not obtain necessary ethics approvals, says Swedish Research Council

Poll: Should there be a statute of limitation on retractions?

With PubPeer and other online resources (such as PubMed Commons and our comment section), it’s never been easier for readers to raise public suspicions of published papers. But what should we do when we learn about potential problems in papers that are decades old, and all of the authors are deceased?

That’s the question we’re asking ourselves, after reading “Due process in the Twitter age,” this week’s editorial from Science editor Marcia McNutt.

She presents this compelling scenario:

Continue reading Poll: Should there be a statute of limitation on retractions?